Skip to main navigation Skip to search Skip to main content

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

  • Mark P. Purdue
  • , Mattias Johansson
  • , Diana Zelenika
  • , Jorge R. Toro
  • , Ghislaine Scelo
  • , Lee E. Moore
  • , Egor Prokhortchouk
  • , Xifeng Wu
  • , Lambertus A. Kiemeney
  • , Valerie Gaborieau
  • , Kevin B. Jacobs
  • , Wong Ho Chow
  • , David Zaridze
  • , Vsevolod Matveev
  • , Jan Lubinski
  • , Joanna Trubicka
  • , Neonila Szeszenia-Dabrowska
  • , Jolanta Lissowska
  • , Péter Rudnai
  • , Eleonora Fabianova
  • Alexandru Bucur, Vladimir Bencko, Lenka Foretova, Vladimir Janout, Paolo Boffetta, Joanne S. Colt, Faith G. Davis, Kendra L. Schwartz, Rosamonde E. Banks, Peter J. Selby, Patricia Harnden, Christine D. Berg, Ann W. Hsing, Robert L. Grubb, Heiner Boeing, Paolo Vineis, Franc̃oise Clavel-Chapelon, Domenico Palli, Rosario Tumino, Vittorio Krogh, Salvatore Panico, Eric J. Duell, José Ramón Quiós, Maria José Sanchez, Carmen Navarro, Eva Ardanaz, Miren Dorronsoro, Kay Tee Khaw, Naomi E. Allen, H. Bas Bueno-De-Mesquita, Petra H.M. Peeters, Dimitrios Trichopoulos, Jakob Linseisen, Börje Ljungberg, Kim Overvad, Anne Tjønneland, Isabelle Romieu, Elio Riboli, Anush Mukeria, Oxana Shangina, Victoria L. Stevens, Michael J. Thun, W. Ryan Diver, Susan M. Gapstur, Paul D. Pharoah, Douglas F. Easton, Demetrius Albanes, Stephanie J. Weinstein, Jarmo Virtamo, Lars Vatten, Kristian Hveem, Inger Njølstad, Grethe S. Tell, Camilla Stoltenberg, Rajiv Kumar, Kvetoslava Koppova, Olivier Cussenot, Simone Benhamou, Egbert Oosterwijk, Sita H. Vermeulen, Katja K.H. Aben, Saskia L. Van Der Marel, Yuanqing Ye, Christopher G. Wood, Xia Pu, Alexander M. Mazur, Eugenia S. Boulygina, Nikolai N. Chekanov, Mario Foglio, Doris Lechner, Ivo Gut, Simon Heath, Hélène Blanche, Amy Hutchinson, Gilles Thomas, Zhaoming Wang, Meredith Yeager, Joseph F. Fraumeni, Konstantin G. Skryabin, James D. McKay, Nathaniel Rothman, Stephen J. Chanock, Mark Lathrop, Paul Brennan
  • National Institutes of Health
  • International Agency for Research on Cancer
  • Institut Génomique, Commissariat À l'Énergie Atomique
  • Russian Academy of Sciences
  • Kurchatov Scientific Center
  • University of Texas MD Anderson Cancer Center
  • Radboud University Nijmegen
  • SAIC
  • Blokhin Cancer Research Center
  • Pomeranian Medical University in Szczecin
  • Nofer Institute of Occupational Medicine
  • Maria Sklodowska-Curie Institute of Oncology
  • Hungarian National Institute of Environmental Health
  • Regional Authority of Public Health
  • National Institute of Public Health
  • Charles University
  • Masaryk Memorial Cancer Institute
  • Palacký University Olomouc
  • University of Illinois at Chicago
  • Wayne State University
  • Leeds Teaching Hospitals NHS Trust
  • Washington University St. Louis
  • German Institute of Human Nutrition Potsdam-Rehbruecke
  • Imperial College London
  • Medical Research Council
  • Human Genetic Foundation (HuGeF)
  • University of Paris Sud
  • Université Paris-Saclay
  • Centro Per Lo Studio E La Prevenzione Oncologica
  • Azienda Ospedaliera Civile M.P. Arezzo
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • University of Naples Federico II
  • Institute Catala Oncologia
  • Jefe Sección Información Sanitaria
  • Escuela Andaluza de Salud Publica
  • CIBER Epidemiología y Salud Pública (CIBERESP)
  • Regional Council of Health and Consumer Affairs
  • Instituto de Salud Publica, Pamplona
  • Public Health Division of Gipuzkoa
  • University of Cambridge
  • University of Oxford
  • National Institute of Public Health and the Environment
  • Utrecht University
  • Harvard University
  • Academy of Athens
  • German Cancer Research Center
  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • Umeå University
  • Aarhus University
  • Danish Cancer Society
  • American Cancer Society
  • National Institute for Health and Welfare
  • Norwegian University of Science and Technology
  • University of Tromsø – The Arctic University of Norway
  • University of Bergen
  • Norwegian Institute of Public Health
  • Tenon Hospital
  • Fondation Jean Dausset - CEPH
  • Institute Gustave Roussy
  • Netherlands Association of Comprehensive Cancer Centres

Research output: Contribution to journalArticlepeer-review

221 Scopus citations

Abstract

We conducted a two-stage genome-wide association study of renal cell carcinoma (RCC) in 3,772 affected individuals (cases) and 8,505 controls of European background from 11 studies and followed up 6 SNPs in 3 replication studies of 2,198 cases and 4,918 controls. Two loci on the regions of 2p21 and 11q13.3 were associated with RCC susceptibility below genome-wide significance. Two correlated variants (r 2 = 0.99 in controls), rs11894252 (P = 1.8 ×- 10-8) and rs7579899 (P = 2.3 ×- 10-9), map to EPAS1 on 2p21, which encodes hypoxia-inducible-factor-2 alpha, a transcription factor previously implicated in RCC. The second locus, rs7105934, at 11q13.3, contains no characterized genes (P = 7.8 ×- 10-14). In addition, we observed a promising association on 12q24.31 for rs4765623, which maps to SCARB1, the scavenger receptor class B, member 1 gene (P = 2.6 ×- 10 -8). Our study reports previously unidentified genomic regions associated with RCC risk that may lead to new etiological insights.

Original languageEnglish
Pages (from-to)60-65
Number of pages6
JournalNature Genetics
Volume43
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Dive into the research topics of 'Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3'. Together they form a unique fingerprint.

Cite this